RBM11

gene
On this page

Summary

RBM11 (RNA binding motif protein 11, HGNC:9897) is a protein-coding gene on chromosome 21q11.2, encoding Splicing regulator RBM11 (P57052). Tissue-specific splicing factor with potential implication in the regulation of alternative splicing during neuron and germ cell differentiation.

Enables poly(U) RNA binding activity and protein homodimerization activity. Acts upstream of or within cellular response to oxidative stress and regulation of alternative mRNA splicing, via spliceosome. Located in nuclear speck.

Source: NCBI Gene 54033 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 51 total
  • MANE Select transcript: NM_144770

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:9897
Approved symbolRBM11
NameRNA binding motif protein 11
Location21q11.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000185272
Ensembl biotypeprotein_coding
OMIM617937
Entrez54033

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 4 protein_coding_CDS_not_defined, 2 protein_coding, 1 retained_intron

ENST00000400577, ENST00000461088, ENST00000468643, ENST00000468788, ENST00000475864, ENST00000495055, ENST00000900829

RefSeq mRNA: 2 — MANE Select: NM_144770 NM_001320602, NM_144770

CCDS: CCDS46635

Canonical transcript exons

ENST00000400577 — 5 exons

ExonStartEnd
ENSE000019392461421615714216282
ENSE000034850521422443814224537
ENSE000035295641422688014228372
ENSE000035462981421956314219725
ENSE000035600601422109714221169

Expression profiles

Bgee: expression breadth ubiquitous, 194 present calls, max score 97.62.

FANTOM5 (CAGE): breadth broad, TPM avg 4.3325 / max 598.0450, expressed in 728 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1884834.0660720
1884840.266477

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
corpus epididymisUBERON:000435997.62gold quality
C1 segment of cervical spinal cordUBERON:000646990.47gold quality
spinal cordUBERON:000224089.37gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.37gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.01gold quality
oocyteCL:000002387.51gold quality
tibial nerveUBERON:000132384.65gold quality
left ovaryUBERON:000211980.97gold quality
Brodmann (1909) area 9UBERON:001354080.81gold quality
prefrontal cortexUBERON:000045180.52gold quality
secondary oocyteCL:000065579.81gold quality
adenohypophysisUBERON:000219679.78gold quality
cortical plateUBERON:000534379.26gold quality
hypothalamusUBERON:000189878.72gold quality
islet of LangerhansUBERON:000000678.54gold quality
right ovaryUBERON:000211878.26gold quality
dorsolateral prefrontal cortexUBERON:000983477.89gold quality
anterior cingulate cortexUBERON:000983577.77gold quality
lower esophagus mucosaUBERON:003583477.54gold quality
left lobe of thyroid glandUBERON:000112077.49gold quality
pituitary glandUBERON:000000777.27gold quality
ovaryUBERON:000099276.72gold quality
right frontal lobeUBERON:000281076.63gold quality
frontal cortexUBERON:000187076.53gold quality
thyroid glandUBERON:000204676.44gold quality
neocortexUBERON:000195076.38gold quality
substantia nigraUBERON:000203876.27gold quality
right lobe of thyroid glandUBERON:000111976.05gold quality
cerebral cortexUBERON:000095674.92gold quality
caput epididymisUBERON:000435874.30gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.81

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

69 targeting RBM11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-5692A100.0074.406850
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-366299.9973.825684
HSA-MIR-318599.9968.121959
HSA-MIR-433-3P99.9869.371203
HSA-MIR-56899.9869.862084
HSA-MIR-548P99.9872.253784
HSA-MIR-485-3P99.9870.681585
HSA-MIR-539-3P99.9870.741616
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-590-3P99.9674.346478
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-335-3P99.9373.364958
HSA-MIR-311999.9271.342390
HSA-MIR-449699.8868.892236
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-465899.7764.94514
HSA-MIR-6790-5P99.7765.24505
HSA-MIR-365999.7067.97694
HSA-MIR-29B-2-5P99.6768.981726

Literature-anchored findings (GeneRIF, showing 2)

  • RBM11 is a representative splicing factor that is upregulated in glioblastoma tumors after therapy and shed in extracellular vesicles upon induction of apoptosis. Once internalized in recipient cells, exogenous RBM11 switches splicing of MDM4 and Cyclin D1 toward the expression of more oncogenic isoforms. (PMID:29937354)
  • RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression. (PMID:34434291)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriorbm11ENSDARG00000090202
mus_musculusRbm11ENSMUSG00000032940
rattus_norvegicusRbm11ENSRNOG00000029147
drosophila_melanogasterCG11454FBGN0031224
caenorhabditis_elegansWBGENE00012558
caenorhabditis_elegansrnp-8WBGENE00020091

Paralogs (1): RBM7 (ENSG00000076053)

Protein

Protein identifiers

Splicing regulator RBM11P57052 (reviewed: P57052)

Alternative names: RNA-binding motif protein 11

All UniProt accessions (1): P57052

UniProt curated annotations — full annotation on UniProt →

Function. Tissue-specific splicing factor with potential implication in the regulation of alternative splicing during neuron and germ cell differentiation. Antagonizes SRSF1-mediated BCL-X splicing. May affect the choice of alternative 5’ splice sites by binding to specific sequences in exons and antagonizing the SR protein SRSF1.

Subunit / interactions. Homodimer.

Subcellular location. Nucleus. Nucleoplasm. Nucleus speckle.

Tissue specificity. Expressed in brain, hippocampus, prefrontal cortex, cerebellum, spinal cord, testis, mammary gland, spleen and kidney. Also expressed in fetal brain.

Miscellaneous. May be produced at very low levels due to a premature stop CC codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoforms (2)

UniProt IDNamesCanonical?
P57052-11yes
P57052-33

RefSeq proteins (2): NP_001307531, NP_658983* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000504RRM_domDomain
IPR012677Nucleotide-bd_a/b_plait_sfHomologous_superfamily
IPR034501RBM11_RRMDomain
IPR035979RBD_domain_sfHomologous_superfamily
IPR052285NEXT_complex_subunitFamily

Pfam: PF00076

UniProt features (18 total): helix 4, strand 3, compositionally biased region 3, splice variant 2, chain 1, domain 1, sequence conflict 1, region of interest 1, short sequence motif 1, sequence variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
2YWKX-RAY DIFFRACTION1.54

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P57052-F161.850.28

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 90 (showing top): GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME, GOBP_RNA_SPLICING, GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME, GOBP_REGULATION_OF_RNA_SPLICING, GOCC_NUCLEAR_SPECK, GOCC_NUCLEAR_BODY, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP, GOCC_RIBONUCLEOPROTEIN_GRANULE, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY, GOMF_POLY_PYRIMIDINE_TRACT_BINDING, GOMF_SINGLE_STRANDED_RNA_BINDING, GOBP_REGULATION_OF_MRNA_PROCESSING, GOBP_MRNA_PROCESSING, GOCC_SUPRAMOLECULAR_COMPLEX

GO Biological Process (5): regulation of alternative mRNA splicing, via spliceosome (GO:0000381), mRNA processing (GO:0006397), RNA splicing (GO:0008380), cell differentiation (GO:0030154), cellular response to oxidative stress (GO:0034599)

GO Molecular Function (6): single-stranded RNA binding (GO:0003727), poly(U) RNA binding (GO:0008266), protein homodimerization activity (GO:0042803), nucleic acid binding (GO:0003676), RNA binding (GO:0003723), protein binding (GO:0005515)

GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), nuclear speck (GO:0016607)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA processing2
binding2
alternative mRNA splicing, via spliceosome1
regulation of mRNA splicing, via spliceosome1
mRNA metabolic process1
cellular developmental process1
response to oxidative stress1
cellular response to chemical stress1
RNA binding1
poly-pyrimidine tract binding1
identical protein binding1
protein dimerization activity1
nucleic acid binding1
intracellular membrane-bounded organelle1
nuclear lumen1
cellular anatomical structure1
nuclear ribonucleoprotein granule1

Protein interactions and networks

STRING

1049 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RBM11RBM25P49756652
RBM11RBM4Q9BWF3616
RBM11KHDRBS1Q07666595
RBM11RBM10P98175594
RBM11MDM4O15151559
RBM11SRSF1Q07955527
RBM11ZCCHC8Q6NZY4517
RBM11HSPA13P48723490
RBM11LIPIQ6XZB0489
RBM11RBM19Q9Y4C8487
RBM11FBF1Q8TES7478
RBM11RBM17Q96I25476
RBM11TRA2BP62995474
RBM11PCBP3P57721473
RBM11SF3B2Q13435454

IntAct

178 interactions, top by confidence:

ABTypeScore
MED4MED19psi-mi:“MI:2364”(proximity)0.900
RBM11ZCCHC8psi-mi:“MI:0914”(association)0.740
QKIRBM11psi-mi:“MI:0915”(physical association)0.560
GABPB1RBM11psi-mi:“MI:0915”(physical association)0.560
RBM11SNRPCpsi-mi:“MI:0915”(physical association)0.560
ZNF774RBM11psi-mi:“MI:0915”(physical association)0.560
RBM11QKIpsi-mi:“MI:0915”(physical association)0.560
SNRPCRBM11psi-mi:“MI:0915”(physical association)0.560
PIBF1RBM11psi-mi:“MI:0915”(physical association)0.560
U2AF2RBM11psi-mi:“MI:0915”(physical association)0.560
RBM11ATOSBpsi-mi:“MI:0915”(physical association)0.560
RBM11GPATCH2Lpsi-mi:“MI:0915”(physical association)0.560
SNRPARBM11psi-mi:“MI:0915”(physical association)0.560
RBM11PIBF1psi-mi:“MI:0915”(physical association)0.560
RBM11SCNM1psi-mi:“MI:0915”(physical association)0.560
RBM11GLIS2psi-mi:“MI:0915”(physical association)0.560
DDX6RBM11psi-mi:“MI:0915”(physical association)0.560
RBM11ZFHX3psi-mi:“MI:0915”(physical association)0.560
RBM11DTX2psi-mi:“MI:0915”(physical association)0.560
RBM11SAXO4psi-mi:“MI:0915”(physical association)0.560
RBM11ZNF414psi-mi:“MI:0915”(physical association)0.560
RBM11GADD45GIP1psi-mi:“MI:0915”(physical association)0.560
RBM11ENKD1psi-mi:“MI:0915”(physical association)0.560

BioGRID (194): RBM11 (Two-hybrid), RBM11 (Two-hybrid), RBM11 (Two-hybrid), ZNF774 (Two-hybrid), SF3B2 (Affinity Capture-MS), SKIV2L2 (Affinity Capture-MS), USP7 (Affinity Capture-MS), SLC4A1AP (Affinity Capture-MS), ZCCHC8 (Affinity Capture-MS), TTC33 (Affinity Capture-MS), RHOXF2 (Two-hybrid), RBM11 (Reconstituted Complex), RBM11 (Proximity Label-MS), DAZAP2 (Two-hybrid), SLC4A1AP (Affinity Capture-MS)

ESM2 similar proteins: A0A087WUL8, A0A0J9YWL9, A0A0J9YY54, A0A1L8G2K9, A6NJ88, A6QL64, B4DH59, B5DUH6, B7SY83, B9G9L9, F4HXQ7, O04492, O77733, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P17772, P48785, P48786, P53353, P57052, Q0DVU4, Q15361, Q3BBV0, Q3BBV2, Q4ZJY7, Q4ZJZ0, Q4ZJZ1, Q4ZJZ3, Q5JPF3, Q5TAG4, Q5TI25, Q5XHX6, Q5ZCC5, Q6P3W6, Q6P902, Q6PGQ1, Q6ZQX7, Q86T75

Diamond homologs: A0A0D1DZT6, A3LXL0, B1WC40, B5FXN8, B5G279, F4HT49, O08583, O22173, O35698, O64380, O75821, O93235, P04147, P19683, P19684, P27476, P29341, P42731, P49313, P49314, P52298, P57052, P60824, P60825, P60826, Q06106, Q08935, Q08937, Q09330, Q10355, Q13595, Q14011, Q1ZXC2, Q28CY2, Q28FB9, Q28IQ9, Q29RT0, Q2GSX8, Q3T0I4, Q3ZBJ1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

51 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance41
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1094 predictions. Top by Δscore:

VariantEffectΔscore
21:14221093:A:AGacceptor_gain1.0000
21:14221093:AAAG:Aacceptor_gain1.0000
21:14221093:AAAGG:Aacceptor_gain1.0000
21:14221094:A:Gacceptor_gain1.0000
21:14221096:GGGA:Gacceptor_gain1.0000
21:14216253:G:GTdonor_gain0.9900
21:14216278:TTCAG:Tdonor_loss0.9900
21:14216280:CAG:Cdonor_loss0.9900
21:14216281:AGG:Adonor_loss0.9900
21:14216282:GGTAC:Gdonor_loss0.9900
21:14216283:G:Adonor_loss0.9900
21:14216284:T:Gdonor_loss0.9900
21:14219712:GC:Gdonor_gain0.9900
21:14221091:TCAAA:Tacceptor_loss0.9900
21:14221092:CAAA:Cacceptor_loss0.9900
21:14221094:AAG:Aacceptor_gain0.9900
21:14221095:A:Gacceptor_gain0.9900
21:14221095:AG:Aacceptor_gain0.9900
21:14221095:AGGG:Aacceptor_loss0.9900
21:14221096:G:GGacceptor_gain0.9900
21:14221096:GG:Gacceptor_gain0.9900
21:14221166:ACAG:Adonor_loss0.9900
21:14221167:CAG:Cdonor_loss0.9900
21:14221169:GG:Gdonor_loss0.9900
21:14221170:GTAAT:Gdonor_loss0.9900
21:14221171:TAATT:Tdonor_loss0.9900
21:14216253:G:Tdonor_gain0.9800
21:14218103:C:CGdonor_gain0.9800
21:14218103:C:Gdonor_gain0.9800
21:14219723:TTGGT:Tdonor_loss0.9800

AlphaMissense

1857 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
21:14216227:T:AV14D1.000
21:14219624:G:AG53E1.000
21:14219630:T:AV55D1.000
21:14219675:T:CL70P1.000
21:14216223:T:CF13L0.999
21:14216225:T:AF13L0.999
21:14216225:T:GF13L0.999
21:14216236:T:CL17S0.999
21:14216263:T:AL26Q0.999
21:14216263:T:CL26P0.999
21:14216272:T:CL29P0.999
21:14216274:T:CF30L0.999
21:14216276:C:AF30L0.999
21:14216276:C:GF30L0.999
21:14219566:G:AG34R0.999
21:14219566:G:CG34R0.999
21:14219566:G:TG34W0.999
21:14219567:G:AG34E0.999
21:14219620:T:CF52L0.999
21:14219622:T:AF52L0.999
21:14219622:T:GF52L0.999
21:14219623:G:AG53R0.999
21:14219623:G:CG53R0.999
21:14219626:T:CF54L0.999
21:14219628:T:AF54L0.999
21:14219628:T:GF54L0.999
21:14219635:T:CF57L0.999
21:14219636:T:CF57S0.999
21:14219637:T:AF57L0.999
21:14219637:T:GF57L0.999

dbSNP variants (sampled 300 via entrez): RS1000085994 (21:14223859 C>A), RS1000444485 (21:14228005 C>G), RS1000531068 (21:14222234 C>A,T), RS1000583269 (21:14221954 A>G), RS1001160195 (21:14216209 C>G), RS1001291083 (21:14228592 A>G,T), RS1001487211 (21:14223750 G>C), RS1001950015 (21:14227598 T>C), RS1002358880 (21:14227862 A>G), RS1002482192 (21:14215499 C>T), RS1002486732 (21:14222575 C>T), RS1002540903 (21:14222396 T>C), RS1002967726 (21:14226121 C>T), RS1002975359 (21:14216365 G>A,C,T), RS1003088434 (21:14220402 C>T)

Disease associations

OMIM: gene MIM:617937 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression3
trichostatin Aaffects expression, increases expression2
p-Chloromercuribenzoic Acidaffects cotreatment, increases expression2
potassium chromate(VI)increases expression1
entinostatincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression, affects cotreatment1
dorsomorphinaffects cotreatment, increases expression1
Vorinostatincreases expression1
Benzo(a)pyreneincreases methylation1
Cadmium Chloridedecreases expression1
S-Nitrosoglutathioneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.